Emulsified Homo (Ciprofloxacin) Polymer Nanoparticles for Antibacterial Applications

We report for the first time a method for forming polyacrylate nanoparticles using N-acryloylciprofloxacin as a sole monomer for emulsion polymerization. The procedure involves a free radical-induced emulsion polymerization of N-acryloylciprofloxacin monomer to produce a stable aqueous emulsion comprising uniformly sized polyacrylate nanoparticles. Dynamic light scattering analysis of the emulsions showed a single population of nanoparticles having an average diameter of 970 nm and average surface charge of -63 mV, indicative of the high stability of the emulsion and significantly enhance lipophilicity of the polymeric matrix of the nanoparticle. Antibacterial testing of the emulsions against the Gram-positive microbe Staphylococcus aureus and the Gram-negative Escherichia coli found in vitro activities identical to those of the reference clinical agent, ciprofloxacin. Assays against human colorectal carcinoma cells and human embryonic kidney cells showed essentially no cytotoxicity. This is the first study on the synthesis of aqueous nanoparticle emulsions assembled solely from a single monomer derived from the antibiotic agent.